Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
  • Resources
    • 2023 Diversity, Equity, & Inclusion Report
    • 2023 Industry Snapshot
    • 2022 Massachusetts Biopharma Funding Report
    • 2022 MA Life Sciences Workforce Analysis Report
    • Economic Development
    • Biopharma Startup Toolkit
    • Career Center
    • MassBioEd
  • Events
    • Events Calendar
    • Overview of Events
    • Get Involved
  • Membership
    • Member Directory
    • Benefits of Membership
    • Savings and Rewards
    • Member News
    • Become a Member
    • Member Rates
    • Pay Company Dues
  • Savings & Rewards
    • MassBioEdge
  • Conference Center
    • MassBioHub
  • Programs
    • Bioversity at Southline Boston
    • State of Possible 2025 Report
    • Diversity, Equity, and Inclusion
    • Policy & Advocacy
    • Partnering Opportunities
    • MassBioDrive
    • Digital Health
    • BioReady Communities
  • About Us
    • About Us
    • News & Thought Leadership
    • Sponsorship Opportunities
    • Staff
    • Board of Directors
    • FAQs
    • Contact Us
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
Open search form

Member Directory

Click to Open Main Menu

AstraZeneca Pharmaceuticals LP

Life Sciences | Drug Development
Waltham, MA 781-839-4000 Website @AstraZeneca

Overview

AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. Our mission is to make a meaningful difference to patient health through great medicines that bring benefit for patients and add value for our stakeholders and society. We discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the world’s most serious illnesses: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

The state-of-the-art AstraZeneca R&D Boston facility, located in Waltham, Massachusetts, reflects the innovative culture of AstraZeneca’s leading-edge pharmaceutical research. Innovative medicine teams focused on infection and oncology conduct research from discovery to Clinical Proof of Concept (PoC-Phase II success). They are joined by scientists trained in safety assessment, pharmaceutical development, R&D Information, predictive science, and personalised healthcare who work collaboratively to help bring to market medicines that deliver value to patients, payers, and prescribers. In addition to these core therapy areas, the site is home to scientists working to identify new opportunities for patient health outside of our existing research areas and professionals involved in business development.

In 2012 AstraZeneca opened its Neuroscience offices in Kendall Square, Cambridge, to pursue a new virtual early discovery/development R&D model that fully relies on collaborations with external partners.

AstraZeneca is also pleased to have a global operations and field-based commercial employees located in Massachusetts.

Company News

News

CoSolve: Forging partnerships to solve research challenges

Feb 09, 2023

Posted by AstraZeneca Pharmaceuticals LP

News

AstraZeneca’s Inubator at the Boston BioHub Welcomes OLARIS!

Nov 19, 2019

Posted by AstraZeneca Pharmaceuticals LP

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • Contact
  • Privacy Policy
  • Fulfillment Policy
  • © 2024 All Rights Reserved